In this episode, a multidisciplinary panel of pulmonology, thoracic surgery and oncology experts discusses real-world lung nodule cases and how noninvasive CyPath® Lung testing can help refine risk stratification. The panel explores when testing may support decisions to pursue biopsy, when a negative result may help avoid unnecessary invasive procedures, and how multidisciplinary collaboration can improve the management of patients with indeterminate lung nodules. The experts also look ahead to the evolving role of noninvasive testing in lung nodule management.